E2F1-dependent MIR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1

Nature Communications

Volumn 6, Issue , 2015, Pages

  Wang, Kun ^a   Zhou, Lu Yu ^a   Wang, Jian Xun ^a   Wang, Yin ^a   Sun, Teng ^a   Zhao, Bing ^a   Yang, Yong Jie ^a   An, Tao ^b   Long, Bo ^c   Li, Na ^c   Liu, Cui Yun ^c   Gong, Ying ^a   Gao, Jin Ning ^a   Dong, Yan Han ^a   Zhang, Jian ^b   Li, Pei Feng ^a  

^a QINGDAO UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MICRORNA; MICRORNA 421; PINK1 PROTEIN; PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; E2F1 PROTEIN, MOUSE; MIRN421 MICRORNA, MOUSE; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE;

APOPTOSIS; GENE EXPRESSION; MITOCHONDRIAL DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HUMAN; MOUSE; NONHUMAN; RNA TRANSLATION; ANIMAL; CARDIAC MUSCLE CELL; ELECTRON MICROSCOPY; GENETICS; IMMUNOBLOTTING; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; E2F1 TRANSCRIPTION FACTOR; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; MICROSCOPY, ELECTRON; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84937559020     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8619     Document Type: Article

References (49)

1. Go, A. S. et al. Executive Summary: Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association. Circulation 129, 399-410 (2014).
2. Ingwall, J. S. Energy metabolism in heart failure and remodelling. Cardiovasc. Res. 81, 412-419 (2009).
3. Chen, Q., Moghaddas, S., Hoppel, C. L. & Lesnefsky, E. J. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am. J. Physiol.-Cell Physiol. 294, C460-C466 (2008).
4. Coughlan, M. T. et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J. Am. Soc. Nephrol. 20, 742-752 (2009).
5. Chen, Y., Liu, Y. & Dorn, G. W. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 109, 1327-1331 (2011).
6. Wang, J. X. et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 17, 71-78 (2011).
7. Ong, S.-B. et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121, 2012-2022 (2010).
8. Chen, H., Chomyn, A. & Chan, D. C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280, 26185-26192 (2005).
9. Abou-Sleiman, P. M., Muqit, M. M. K. & Wood, N. W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7, 207-219 (2006).
10. Fedorowicz, M. A. et al. Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy. EMBO Rep. 15, 86-93 (2014).
11. Yang, Y. et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl Acad. Sci. USA 105, 7070-7075 (2008).
12. Dagda, R. K. et al. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284, 13843-13855 (2009).
13. Siddall, H. K. et al. Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury. PloS ONE 8, e62400 (2013).
14. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419 (2003).
15. Ohtani, K. & Dimmeler, S. Control of cardiovascular differentiation by microRNAs. Basic Res. Cardiol. 106, 5-11 (2011).
16. Hsieh, M. C., Das, D., Sambandam, N., Zhang, M. Q. & Nahlé, Z. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J. Biol. Chem. 283, 27410-27417 (2008).
17. Ikeda, S. et al. Altered microRNA expression in human heart disease. Physiol. Genomics 31, 367-373 (2007).
18. Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317 (2007).
19. Cloud, J. E. et al. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell. Biol. 22, 2663-2672 (2002).
20. Angelis, E., Zhao, P., Zhang, R., Goldhaber, J. I. & Maclellan, W. R. The role of E2F-1 and downstream target genes in mediating ischemia/reperfusion injury in vivo. J. Mol. Cell. Cardiol. 51, 919-926 (2011).
21. Ziviani, E., Tao, R. N. & Whitworth, A. J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl Acad. Sci. USA 107, 5018-5023 (2010).
22. Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA 107, 378-383 (2010).
23. Wang, X. et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893-906 (2011).
24. Chen, Y. & Dorn, G. W. 2nd PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340, 471-475 (2013).
25. Pridgeon, J. W., Olzmann, J. A., Chin, L. S. & Li, L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5, e172 (2007).
26. Choi, W. Y., Giraldez, A. J. & Schier, A. F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318, 271-274 (2007).
27. Bujak, M. & Frangogiannis, N. G. The role of TGF-b signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74, 184-195 (2007).
28. Vigneron, F. et al. GSK-3b at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Cardiovasc. Res. 90, 49-56 (2011).
29. Tsang, A., Hausenloy, D. J., Mocanu, M. M. & Yellon, D. M. Postconditioning: a form of ''modified reperfusion'' protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95, 230-232 (2004).
30. Ren, X.-P. et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119, 2357-2366 (2009).
31. Roy, S. et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21-29 (2009).
32. Wang, X. et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122, 1308-1318 (2010).
33. Abeliovich, A. Parkinson's disease: pro-survival effects of PINK1. Nature 448, 759-760 (2007).
34. Exner, N. et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27, 12413-12418 (2007).
35. Kamp, F. et al. Inhibition of mitochondrial fusion by a-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29, 3571-3589 (2010).
36. Petit, A. et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025 (2005).
37. Wang, J.-X. et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 17, 71-78 (2011).
38. Zhang, W. et al. Mitofusin-2 protects against cold stress-induced cell injury in HEK293 cells. Biochem. Biophys. Res. Commun. 397, 270-276 (2010).
39. Estaquier, J. & Arnoult, D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 14, 1086-1094 (2007).
40. Chen, L., Gong, Q., Stice, J. P. & Knowlton, A. A. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 84, 91 (2009).
41. Matkovich, S. J., Van Booven, D. J., Eschenbacher, W. H. & Dorn, G. W., 2nd RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 108, 18-26 (2011).
42. Kim, H. W., Haider, H. K., Jiang, S. & Ashraf, M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 284, 33161-33168 (2009).
43. Zhao, L., Bode, A. M., Cao, Y. & Dong, Z. Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis 33, 2220-2227 (2012).
44. Guo, J. et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 24, 652-657 (2009).
45. Zhang, Y. et al. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol. Cancer Res. 10, 516-522 (2012).
46. Hao, J. et al. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem. Biophys. Res. Commun. 406, 552-557 (2011).
47. Hu, H., Du, L., Nagabayashi, G., Seeger, R. C. & Gatti, R. A. ATM is downregulated by N-Myc-regulated microRNA-421. Proc. Natl Acad. Sci. USA 107, 1506-1511 (2010).
48. DeGregori, J. & Johnson, D. G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6, 739-748 (2006).
49. Stiewe, T. & Pützer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469 (2000).